Smith Salley Wealth Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$13.2M |
| 2 |
Colgate-Palmolive
CL
|
+$9.39M |
| 3 |
AstraZeneca
AZN
|
+$9.12M |
| 4 |
Broadcom
AVGO
|
+$4.67M |
| 5 |
Microsoft
MSFT
|
+$4.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Constellation Brands
STZ
|
+$11.7M |
| 2 |
Merck
MRK
|
+$9.54M |
| 3 |
Paychex
PAYX
|
+$2.42M |
| 4 |
Gartner
IT
|
+$2.38M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.2% |
| 2 | Financials | 16.77% |
| 3 | Consumer Discretionary | 9.29% |
| 4 | Healthcare | 9.28% |
| 5 | Industrials | 8.52% |
Similar funds
Smith Salley Wealth Management's Q3 2025 Portfolio in Review
As of Q3 2025, Smith Salley Wealth Management held 272 positions worth $1.94B, up 12% from $1.73B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Smith Salley Wealth Management deployed $68.1M of net new capital in Q3 2025, opening 17 new positions and adding to 120 existing holdings. Its largest new stake was Nike: 12,152 shares worth $847K.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Merck, an estimated $9.54M trimmed.
- Smith Salley Wealth Management's largest Q3 2025 buy was Nike: 12,152 shares worth $847K.
- Smith Salley Wealth Management added most to Eli Lilly in Q3 2025, an estimated $13.2M increase.
- Smith Salley Wealth Management's biggest Q3 2025 reduction was Merck, cutting an estimated $9.54M.
- Smith Salley Wealth Management fully exited Constellation Brands in Q3 2025, selling an estimated $11.7M.
- Smith Salley Wealth Management's ten largest holdings make up 39% of its $1.94B portfolio in Q3 2025.
- Smith Salley Wealth Management opened 17 new positions and closed 9 in Q3 2025.
- Smith Salley Wealth Management's portfolio value rose 12% quarter-over-quarter to $1.94B.
Based on Smith Salley Wealth Management's 13F filing for Q3 2025, filed 20 Oct 2025.